Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients&...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8a3719f0497f496ea8119b5eec5ecf4b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|